Vigil Neuroscience to be Acquired by Sanofi for $600 Million
Deal News | May 23, 2025 | Fried Frank
Vigil Neuroscience, a clinical-stage biotechnology company focused on treating neurodegenerative diseases, is to be acquired by Sanofi, a prominent French pharmaceutical firm, for a total transaction value of $600 million. Vigil Neuroscience, known for its innovation in harnessing microglia, was advised by Centerview Partners, with crucial legal counsel provided by Fried Frank. Partner Roy Tannenbaum spearheaded the legal advice team. This acquisition marks a significant move for Sanofi as it continues to strengthen its position in the pharmaceutical and healthcare industry.
Sectors
- Biotechnology
- Pharmaceuticals
Geography
- France – Sanofi, the acquiring company, is a French multinational corporation.
- United States – Vigil Neuroscience, the target company, is based in the United States and listed on NASDAQ.
Industry
- Biotechnology – Vigil Neuroscience is a clinical-stage biotechnology company focusing on neurodegenerative diseases, making this industry classification pertinent.
- Pharmaceuticals – Sanofi is a multinational pharmaceutical company acquiring Vigil Neuroscience, which is relevant to the pharmaceutical industry classification.
Financials
- $600 million – The total transaction value for the acquisition of Vigil Neuroscience by Sanofi.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Vigil Neuroscience, Inc. | Target | Company | A clinical-stage biotechnology company focused on the treatment of neurodegenerative diseases. |
| Sanofi | Acquirer | Company | A French multinational pharmaceutical and healthcare company acquiring Vigil Neuroscience. |
| Centerview Partners | Financial Advisor | Company | Acted as financial advisor to Vigil Neuroscience during the acquisition process. |
| Fried Frank | Legal Advisor | Company | Provided legal counseling to Centerview Partners, led by partner Roy Tannenbaum. |
| Roy Tannenbaum | Lead Partner | Person | Partner at Fried Frank who led the legal team advising on the acquisition. |